AU2007346006B2 - Method for the preparation of modified bacteriophages by insertion of random sequences in the targeting proteins of said bacteriophages - Google Patents

Method for the preparation of modified bacteriophages by insertion of random sequences in the targeting proteins of said bacteriophages Download PDF

Info

Publication number
AU2007346006B2
AU2007346006B2 AU2007346006A AU2007346006A AU2007346006B2 AU 2007346006 B2 AU2007346006 B2 AU 2007346006B2 AU 2007346006 A AU2007346006 A AU 2007346006A AU 2007346006 A AU2007346006 A AU 2007346006A AU 2007346006 B2 AU2007346006 B2 AU 2007346006B2
Authority
AU
Australia
Prior art keywords
bacteriophage
bacteriophages
bank
protein
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007346006A
Other languages
English (en)
Other versions
AU2007346006A1 (en
Inventor
Francois Iris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phaxiam Therapeutics SA
Original Assignee
Pherecydes Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherecydes Pharma SA filed Critical Pherecydes Pharma SA
Publication of AU2007346006A1 publication Critical patent/AU2007346006A1/en
Application granted granted Critical
Publication of AU2007346006B2 publication Critical patent/AU2007346006B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AU2007346006A 2006-12-20 2007-12-18 Method for the preparation of modified bacteriophages by insertion of random sequences in the targeting proteins of said bacteriophages Ceased AU2007346006B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0655721 2006-12-20
FR0655721A FR2910492B1 (fr) 2006-12-20 2006-12-20 Procede de preparation de bacteriophages modifies par insertion de sequences aleatoires dans les proteines de ciblage desdits bacteriophages
PCT/FR2007/002101 WO2008093009A2 (fr) 2006-12-20 2007-12-18 Procédé de préparation de bactériophages modifiés par insertion de séquences aléatoires dans les protéines de ciblage desdits bactériophages

Publications (2)

Publication Number Publication Date
AU2007346006A1 AU2007346006A1 (en) 2008-08-07
AU2007346006B2 true AU2007346006B2 (en) 2013-08-29

Family

ID=38293109

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007346006A Ceased AU2007346006B2 (en) 2006-12-20 2007-12-18 Method for the preparation of modified bacteriophages by insertion of random sequences in the targeting proteins of said bacteriophages

Country Status (7)

Country Link
US (1) US9315803B2 (https=)
EP (2) EP2653536A1 (https=)
JP (1) JP2010512774A (https=)
AU (1) AU2007346006B2 (https=)
CA (1) CA2673579C (https=)
FR (1) FR2910492B1 (https=)
WO (1) WO2008093009A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2945049B1 (fr) 2009-04-30 2013-10-04 Pherecydes Pharma Modification du genome d'un bacteriophage lytique par immobilisation dudit bacteriophage dans sa bacterie hote
WO2017174809A1 (en) * 2016-04-08 2017-10-12 Phico Therapeutics Ltd Modifying bacteriophage
CN112823206B (zh) * 2018-10-17 2024-04-16 深圳华大生命科学研究院 从细菌全基因组序列中挖掘温和型噬菌体的方法、装置和存储介质
US11724057B2 (en) 2019-12-16 2023-08-15 Melissa H. Egts Protective, sanitary, securable nasal cannula cover
USD942002S1 (en) 2019-12-16 2022-01-25 Melissa H. Egts Nasal cannula cover
DE102024113842A1 (de) * 2024-05-16 2025-11-20 bifa Umweltinstitut GmbH Verfahren zur Verringerung der bakteriellen Last auf bzw. in einer Klimaanlage

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066224A2 (en) * 2004-12-14 2006-06-22 Yale University Virulence targeted antibiotics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270939B (it) * 1993-05-11 1997-05-26 Angeletti P Ist Richerche Bio Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili.
US6203986B1 (en) * 1998-10-22 2001-03-20 Robert H. Singer Visualization of RNA in living cells
CA2430501A1 (en) 2000-01-11 2001-07-19 Intralytix, Inc. Method for produce sanitation using bacteriophages
ES2252263T3 (es) * 2000-07-25 2006-05-16 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Bacteriofago que tiene una gama de hospedadores multiple.
GB0028130D0 (en) * 2000-11-17 2001-01-03 Phico Therapeutics Ltd Polypeptide and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066224A2 (en) * 2004-12-14 2006-06-22 Yale University Virulence targeted antibiotics

Also Published As

Publication number Publication date
JP2010512774A (ja) 2010-04-30
US9315803B2 (en) 2016-04-19
WO2008093009A2 (fr) 2008-08-07
AU2007346006A1 (en) 2008-08-07
WO2008093009A8 (fr) 2009-07-16
CA2673579A1 (fr) 2008-08-07
WO2008093009A3 (fr) 2009-02-12
EP2097516A2 (fr) 2009-09-09
FR2910492A1 (fr) 2008-06-27
US20110027231A1 (en) 2011-02-03
FR2910492B1 (fr) 2013-02-15
CA2673579C (fr) 2019-04-09
EP2653536A1 (fr) 2013-10-23
EP2097516B1 (fr) 2012-11-14

Similar Documents

Publication Publication Date Title
Schneider Bacteriophage-mediated horizontal gene transfer: transduction
EP1029040B1 (en) Method of increasing efficiency of directed evolution of a gene using phagemid
Lynch et al. Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex
AU2007346006B2 (en) Method for the preparation of modified bacteriophages by insertion of random sequences in the targeting proteins of said bacteriophages
CN108135949A (zh) 递送媒介物
JP2010512774A5 (https=)
US4332897A (en) Novel bacteriophage and method for preparing same
Ceyssens et al. Isolation and Characterization of lytic bacteriophages infecting Pseudomonas aerugionsa
Wang et al. Uncovering the determinants of model Escherichia coli strain C600 susceptibility and resistance to lytic T4-like and T7-like phage
AU2018217936A1 (en) Rebooting of synthetic bacteriophage genome in L-form bacteria
AU2007346007B2 (en) Method for the random diversification of a genetic sequence while preserving the identity of some inner segments of said genetic sequence
Aljarbou et al. Genotyping, morphology and molecular characteristics of a lytic phage of Neisseria strain obtained from infected human dental plaque
CN114934059A (zh) 高通量简化噬菌体基因组骨架的方法
Halmillawewa Isolation, characterization, and applications of rhizobiophages
Parcey The Role of CRISPR-Mediated Phage Resistance in the Development of Phage-Based Biocontrol for Erwinia amylovora
Shmidov et al. An efficient, counterselection-based method for prophage curing in Pseudomonas aerug-inosa strains. Viruses 2021; 13: 336
Knezevic et al. Phages from genus Bruynoghevirus and phage therapy: Pseudomonas phage delta case. Viruses 2021; 13: 1965
WO2025008620A1 (en) Bacteriophage compositions
Alharby Isolation and characterization of a novel bacteriophage, ASC10, that lyses Francisella tularensis
Liu Parasite adaptations to dynamic hosts: Bordetella-phage and Bordetella-host interactions
Glass Bacteriophages
OWUSU-BINEY et al. GENETIC MATERIAL
Yagubi Phage-mediated biological control of Erwinia amylovora

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)